Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Apr 08, 2025
Read More Apparatus The New Generation Of Breast Cancer SERD Drug, Elastoxan, Shows Promise! Mar 22, 2025
Read More Apparatus J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Apr 06, 2025